Personnel Information

写真a

TAMURA Akiko


Job title

Project Assistant Professor
To the head of this page.▲

Campus Career 【 display / non-display 】

  • 2018.04
    -
    Now
    Institute of Science Tokyo， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Systemic Organ Regulation， Gastroenterology and Hepatology， Graduate Student
  • 2018.04
    -
    2023.03
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Division of Systemic Organ Regulation， Department of Gastroenterology and Hepatology， Graduate Student
  • 2023.04
    -
    2024.09
    Tokyo Medical and Dental University， Tokyo Medical and Dental University， Division of Clinical Medicine， Department of Internal Medicine， Gastroenterology and Hepatology， Project Assistant Professor
  • 2024.10
    -
    Now
    Institute of Science Tokyo， -， Institute of Science Tokyo Hospital， Department of Internal Medicine， Gastroenterology and Hepatology， Project Assistant Professor
To the head of this page.▲
 

Published Papers & Misc 【 display / non-display 】

  1. Keitaro Shibuya, Akiko Tamura, Daiki Yafuso, Ami Kawamoto, Shuji Hibiya, Kento Takenaka, Hiromichi Shimizu, Toshimitsu Fujii, Kazuo Ohtsuka, Ryuichi Okamoto. Case Report of a Rapidly Progressive Indolent T-Cell Lymphoma of the Gastrointestinal Tract. DEN Open. 2027.04; 7 e70340. ( PubMed, DOI )

  2. Ryo Morikawa, Toshimitsu Fujii, Akiko Tamura, Ami Kawamoto, Shuji Hibiya, Kento Takenaka, Hiromichi Shimizu, Kazuo Ohtsuka, Ryuichi Okamoto. Real-world data on the effectiveness of risankizumab as induction therapy for ustekinumab-refractory ulcerative colitis. Intest Res. 2026.08; ( PubMed, DOI )

  3. Kento Takenaka, Ami Kawamoto, Shuji Hibiya, Akiko Tamura, Ryo Morikawa, Hiromichi Shimizu, Toshimitsu Fujii, Kazuo Ohtsuka, Ryuichi Okamoto. Stricture dynamics and prognosis during biologic therapy in ileal Crohn's disease: a real-world cohort. Inflamm Bowel Dis. 2026.07; 32 (7): 1211-1218. ( PubMed, DOI )

  4. Akiko Tamura, Toshimitsu Fujii, Shun Fujiwara, Chiaki Maeyashiki, Ryo Morikawa, Ami Kawamoto, Shuji Hibiya, Kento Takenaka, Hiromichi Shimizu, Kazuo Ohtsuka, Ryuichi Okamoto. Efficacy and Rapid Response of Ustekinumab for Hospitalized Patients With Severe Ulcerative Colitis. Inflamm Bowel Dis. 2026.05; 32 (5): 1005-1008. ( PubMed, DOI )

  5. Ami Kawamoto, Toshimitsu Fujii, Shohei Tanaka, Sho Watanabe, Shohei Tomii, Kento Takenaka, Shuji Hibiya, Ryo Morikawa, Akiko Tamura, Hiromichi Shimizu, Masayuki Kurosaki, Tsunehito Yauchi, Kazuo Ohtsuka, Ryuichi Okamoto. Leucine-Rich Alpha-2 Glycoprotein Is an Accurate Serum Marker for Endoscopic and Histological Remission in Ulcerative Colitis. Inflamm Intest Dis. 2026; 11 (1): 139-146. ( PubMed, DOI )

  6. Ryo Morikawa, Toshimitsu Fujii, Akiko Tamura, Ami Kawamoto, Shuji Hibiya, Kento Takenaka, Hiromichi Shimizu, Yoshihito Kano, Mitsukuni Suenaga, Yasuo Hamamoto, Kazuo Ohtsuka, Ryuichi Okamoto. Diagnostic Performance of Fecal Biomarkers and Their Correlation with Endoscopic Severity in Immune Checkpoint Inhibitor-Related Colitis. Digestion. 2025.12; 1-10. ( PubMed, DOI )

  7. Akiko Tamura, Hiromichi Shimizu, Toshimitsu Fujii, Ami Kawamoto, Ryo Morikawa, Shuji Hibiya, Kento Takenaka, Masakazu Nagahori, Kazuo Ohtsuka, Ryuichi Okamoto. Comparative short-term efficacy of upadacitinib versus tofacitinib for ulcerative colitis: a 24-week real-world study in Japan. Intest Res. 2025.03; ( PubMed, DOI )

  8. Shintaro Akiyama, Hiromichi Shimizu, Akiko Tamura, Kaoru Yokoyama, Toshiyuki Sakurai, Mariko Kobayashi, Makoto Eizuka, Shunichi Yanai, Kei Nomura, Tomoyoshi Shibuya, Masahiro Takahara, Sakiko Hiraoka, Minako Sako, Atsushi Yoshida, Kozo Tsuruta, Shinichiro Yoshioka, Miki Koroku, Teppei Omori, Masayuki Saruta, Takayuki Matsumoto, Ryuichi Okamoto, Kiichiro Tsuchiya, Toshimitsu Fujii. Comparative Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis: A Real-World Multicentre Study in Japan. Aliment Pharmacol Ther. 2025.02; 61 (3): 524-537. ( PubMed, DOI )

  9. Shintaro Akiyama, Hiromichi Shimizu, Akiko Tamura, Kaoru Yokoyama, Toshiyuki Sakurai, Mariko Kobayashi, Makoto Eizuka, Shunichi Yanai, Kei Nomura, Tomoyoshi Shibuya, Masahiro Takahara, Sakiko Hiraoka, Minako Sako, Atsushi Yoshida, Kozo Tsuruta, Shinichiro Yoshioka, Miki Koroku, Teppei Omori, Masayuki Saruta, Takayuki Matsumoto, Ryuichi Okamoto, Kiichiro Tsuchiya, Toshimitsu Fujii. Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis Patients over and under 65 Years of Age: A Real-World Comparative Analysis. Inflamm Intest Dis. 2025; 10 (1): 180-186. ( PubMed, DOI )

  10. Ryo Morikawa, Toshimitsu Fujii, Akiko Tamura, Ami Kawamoto, Shuji Hibiya, Kento Takenaka, Hiromichi Shimizu, Kazuo Ohtsuka, Ryuichi Okamoto. Real-World Data on the Effectiveness of Ustekinumab and Risankizumab for Crohn's Disease. Inflamm Intest Dis. 2025; 10 (1): 285-289. ( PubMed, DOI )

  11. Akiko Tamura, Go Ito, Hiroki Matsuda, Yoichi Nibe-Shirakihara, Yuichi Hiraoka, Sayuki Kitagawa, Yui Hiraguri, Sayaka Nagata, Emi Aonuma, Kana Otsubo, Yasuhiro Nemoto, Takashi Nagaishi, Mamoru Watanabe, Ryuichi Okamoto, Shigeru Oshima. Zranb1-mutant mice display abnormal colonic mucus production and exacerbation of DSS-induced colitis. Biochem Biophys Res Commun. 2022.11; 628 147-154. ( PubMed, DOI )

  12. Hiroki Matsuda, Yoichi Nibe-Shirakihara, Akiko Tamura, Emi Aonuma, Satoko Arakawa, Kana Otsubo, Yasuhiro Nemoto, Takashi Nagaishi, Kiichiro Tsuchiya, Shigeomi Shimizu, Averil Ma, Mamoru Watanabe, Motohiro Uo, Ryuichi Okamoto, Shigeru Oshima. Nickel particles are present in Crohn's disease tissue and exacerbate intestinal inflammation in IBD susceptible mice. Biochem Biophys Res Commun. 2022.02; 592 74-80. ( PubMed, DOI )

  13. Emi Aonuma, Akiko Tamura, Hiroki Matsuda, Takehito Asakawa, Yuriko Sakamaki, Kana Otsubo, Yoichi Nibe, Michio Onizawa, Yasuhiro Nemoto, Takashi Nagaishi, Kiichiro Tsuchiya, Tetsuya Nakamura, Motohiro Uo, Mamoru Watanabe, Ryuichi Okamoto, Shigeru Oshima. Nickel ions attenuate autophagy flux and induce transglutaminase 2 (TG2) mediated post-translational modification of SQSTM1/p62. Biochem Biophys Res Commun. 2021.02; 542 17-23. ( PubMed, DOI )

  14. Kana Otsubo, Chiaki Maeyashiki, Yoichi Nibe, Akiko Tamura, Emi Aonuma, Hiroki Matsuda, Masanori Kobayashi, Michio Onizawa, Yasuhiro Nemoto, Takashi Nagaishi, Ryuichi Okamoto, Kiichiro Tsuchiya, Tetsuya Nakamura, Satoru Torii, Eisuke Itakura, Mamoru Watanabe, Shigeru Oshima. Receptor-Interacting Protein Kinase 3 (RIPK3) inhibits autophagic flux during necroptosis in intestinal epithelial cells. FEBS Lett. 2020.05; 594 (10): 1586-1595. ( PubMed, DOI )

▼display all

To the head of this page.▲

Conference Activities & Talks 【 display / non-display 】

  1. 清水寛路,田村皓子,小林桜子,河本亜美,日比谷秀爾,竹中健人,藤井俊光,長堀正和,大塚和朗,岡本隆一. Acute Severe Ulcerative Colitis に対するUpadacitinib の使用成績. 第112回日本消化器病学会 2026.04.16 石川県立音楽堂

  2. Kana Otsubo, Yoichi Nibe, Chiaki Maeyashiki, Akiko Tamura, Emi Aonuma, Hiroki Matsuda, Mamoru Watanabe, Shigeru Oshima. The role of ubiquitination in crosstalk of intestinal epithelial cell death and autophagic signaling was revealed by a novel polyubiquitin imaging system.. 19th International congress of mucosal immunology 2019.07.17 the Brisbane Convention & Exhibition Centre(Brisbane, Australia)

  3. Shigeru Oshima, Yoichi Nibe, Akiko Tamura, Hiroki Matsuda, Emi Aonuma, Kana Otsubo, Mamoru Watanabe. K33-linked polyubiquitin is recruited by SQSTM1/p62. Keystone Symposia: Autophagy(B2) 2019.02.19 Eldorado Hotel &Spa（Santa Fe, New Mexico, USA ）

To the head of this page.▲